Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
2024 — Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing ... Single-Dose Gene Therapy Is ...
Nadofaragene firadenovec appears effective in real-world patients with bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer ...
This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...
Cellevate AB, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing ...
Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of ...
Bryan Johnson wants to be ever young, Elon Musk wants to live on Mars and Artificial General Intelligence promises to ...
News Medical on MSN14d
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessmentsMaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the ...
In a strong validation of the company’s clinical trial, Imugene Ltd’s Phase 1b trial for its azer-cel off-the-shelf, allogeneic, CD19 CAR T therapy in relapsed/refractory diffuse large B-cell lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback